25 results
DEFA14A
LABP
Landos Biopharma Inc
25 Mar 24
Additional proxy soliciting materials
9:19am
’ talented team and their commitment to our mission of creating oral treatments that can address a therapeutic gap,” said Gregory Oakes, president and chief …
AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges
8-K
EX-99.1
LABP
Landos Biopharma Inc
25 Mar 24
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
8:54am
.
“This announcement is a testament to Landos’ talented team and their commitment to our mission of creating oral treatments that can address … LLP is serving as legal advisor.
About AbbVie
AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health
8-K
EX-99.1
LABP
Landos Biopharma Inc
21 Mar 24
Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Results
8:08am
with autoimmune diseases. Our mission is to create safer and more effective oral treatments that address the therapeutic gap in the current treatment paradigm
8-K
EX-99.1
LABP
Landos Biopharma Inc
21 Nov 23
Landos Biopharma Publishes Results of NX-13 Phase 1b Study in Ulcerative Colitis in Journal of Crohn’s and Colitis
8:08am
mission is to create safer and more effective treatments that address the therapeutic gap in the current treatment paradigm.
We have a portfolio of novel
8-K
EX-99.1
vy853m1wv66 2an4
9 Nov 23
Landos Biopharma Provides Company Update and Reports Third Quarter 2023 Results
8:08am
8-K
EX-99.1
2483pxatjslggwjh570
14 Sep 23
Collaboration Will Focus on Defining the Effects Of NX-13 in Ulcerative Colitis Patient Derived Organoid Models
8:11am
8-K
EX-99.1
3lkt5kjrt
9 Aug 23
Landos Biopharma Provides Business Update & Reports Second Quarter 2023 Results
8:12am
8-K
EX-99.1
c8266 p7ezb181
30 May 23
Departure of Directors or Certain Officers
4:53pm
8-K
EX-99.1
dr93g
25 May 23
Landos Biopharma Announces 1-for-10 Reverse Stock Split
4:19pm
8-K
EX-99.1
0tb97qpdlx0ufou98ow
12 May 23
Landos Biopharma Provides Business Update and Reports First Quarter 2023 Results
8:40am
8-K
EX-99.2
2156u urjv7b9b9wgma
11 Aug 22
Landos Biopharma Reports Second Quarter 2022 Results and Provides Business Update
8:54am
8-K
EX-99.1
52r58 646rxc5mole0
11 Aug 22
Landos Biopharma Reports Second Quarter 2022 Results and Provides Business Update
8:54am
8-K
EX-99.1
gy5 33baie
10 Mar 22
Landos Biopharma Appoints Roger Adsett to its Board of Directors
8:20am
8-K
EX-99.2
pui8vr
17 May 21
Landos Biopharma Reports First Quarter 2021 Financial Results and Provides Business Updates
9:23am
10-K
y0qad
31 Mar 21
Annual report
5:03pm
424B4
z1qttmi 0md
4 Feb 21
Prospectus supplement with pricing info
5:02pm
S-1/A
bm43ifzk1 ui
28 Jan 21
IPO registration (amended)
9:12am